Mauda-Havakuk M, Mikhail AS, Starost MF, Jones EC, Karim B, Kleiner DE, Partanen A, Esparza-Trujillo JA, Bakhutashvili I, Wakim PG, Kassin MT, Lewis AL, Karanian JW, Wood BJ, Pritchard WF

Journal of Hepatocellular Carcinoma 2021, 8:71-83

Published Date: 9 March 2021

Original Research

Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy

De B, Ng SP, Liu AY, Avila S, Tao R, Holliday EB, Brownlee Z, Kaseb A, Lee S, Raghav K, Vauthey JN, Minsky BD, Herman JM, Das P, Smith GL, Taniguchi CM, Krishnan S, Crane CH, Grassberger C, Hong TS, Lin SH, Koong AC, Mohan R, Koay EJ

Journal of Hepatocellular Carcinoma 2021, 8:57-69

Published Date: 3 March 2021

Review

Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes

Shi T, Kobara H, Oura K, Masaki T

Journal of Hepatocellular Carcinoma 2021, 8:45-55

Published Date: 11 February 2021

Original Research

Efficacy of Local Therapy for Oligometastatic Hepatocellular Carcinoma: A Propensity Score Matched Analysis

Kim K, Kim TH, Kim TH, Seong J

Journal of Hepatocellular Carcinoma 2021, 8:35-44

Published Date: 11 February 2021

Original Research

The Significance of Gamma-Glutamyl Transpeptidase to Lymphocyte Count Ratio in the Early Postoperative Recurrence Monitoring and Prognosis Prediction of AFP-Negative Hepatocellular Carcinoma

Li S, Xu W, Liao M, Zhou Y, Weng J, Ren L, Yu J, Liao W, Huang Z

Journal of Hepatocellular Carcinoma 2021, 8:23-33

Published Date: 9 February 2021

Perspectives

Targeting De Novo Lipogenesis and Cholesterol Biosynthesis Simultaneously is a Novel Therapeutic Option for Hepatocellular Carcinoma

Liu Q, Dong X

Journal of Hepatocellular Carcinoma 2021, 8:19-21

Published Date: 28 January 2021

Review

Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma

Ely A, Bloom K, Maepa MB, Arbuthnot P

Journal of Hepatocellular Carcinoma 2021, 8:1-17

Published Date: 27 January 2021

Original Research

Effect of Inhibiting Tumor Angiogenesis After Embolization in the Treatment of HCC with Apatinib-Loaded p(N-Isopropyl-Acrylamide-co-Butyl Methyl Acrylate) Temperature-Sensitive Nanogel

Zhou C, Shi Q, Liu J, Huang S, Yang C, Xiong B

Journal of Hepatocellular Carcinoma 2020, 7:447-456

Published Date: 31 December 2020

Review

Efficacy of Local Treatments for Hepatocellular Carcinoma Involving the Inferior Vena Cava and/or Right Atrium

Lee HA, Rim CH

Journal of Hepatocellular Carcinoma 2020, 7:435-446

Published Date: 21 December 2020

Expert Opinion

Potential Impact of IMbrave150 Results in the Evolving Treatment Landscape of Advanced Hepatocellular Carcinoma: A Multidisciplinary Expert Opinion

Kulik L, da Fonseca LG, He AR, Rimola J, Wilson Woods A, Zöllner YF, Galle PR

Journal of Hepatocellular Carcinoma 2020, 7:423-433

Published Date: 21 December 2020

Review

Serum Tumor Markers for Early Diagnosis of Primary Hepatocellular Carcinoma

Zong J, Fan Z, Zhang Y

Journal of Hepatocellular Carcinoma 2020, 7:413-422

Published Date: 18 December 2020

Original Research

Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion

Han S, Lee HW, Park JY, Kim SU, Kim DY, Ahn SH, Han KH, Seong J, Won JY, Han DH, Kim BK

Journal of Hepatocellular Carcinoma 2020, 7:403-412

Published Date: 17 December 2020

Original Research

Increased Expression of Programmed Death Ligand 1 in Hepatocellular Carcinoma of Patients with Hepatitis B Virus Pre-S2 Mutant

Teng CF, Li TC, Wang T, Wu TH, Wang J, Wu HC, Shyu WC, Su IJ, Jeng LB

Journal of Hepatocellular Carcinoma 2020, 7:385-401

Published Date: 17 December 2020

Original Research

Can Immediately Treating Subcentimeter Hepatocellular Carcinoma Improve the Survival of Patients?

Sun X, Hu D, Zhang Y, Lyu N, Xu L, Chen Q, Lai J, Chen M, Zhao M

Journal of Hepatocellular Carcinoma 2020, 7:377-384

Published Date: 16 December 2020

Original Research

Effects of LRP1B Regulated by HSF1 on Lipid Metabolism in Hepatocellular Carcinoma

Li M, Hu J, Jin R, Cheng H, Chen H, Li L, Guo K

Journal of Hepatocellular Carcinoma 2020, 7:361-376

Published Date: 8 December 2020

Review

Timing of DAA Initiation After Curative Treatment and Its Relationship with the Recurrence of HCV-Related HCC

Gao X, Zhan M, Wang L, Ding Y, Niu J

Journal of Hepatocellular Carcinoma 2020, 7:347-360

Published Date: 1 December 2020

Original Research

Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy

Sun X, Hu D, Yang Z, Liu Z, Wang J, Chen J, Xu L, Zhou Z, Chen M, Zhang Y

Journal of Hepatocellular Carcinoma 2020, 7:337-345

Published Date: 1 December 2020

Original Research

Value of Follow-Up Chest Computed Tomography in the Surveillance of Patients with Hepatocellular Carcinoma

Moawad AW, Elsayes KM, Benamar F, Rao K, Sun J, Szklaruk J

Journal of Hepatocellular Carcinoma 2020, 7:331-335

Published Date: 18 November 2020

Original Research

Development and Verification of the Hypoxia-Related and Immune-Associated Prognosis Signature for Hepatocellular Carcinoma

Hu B, Yang XB, Sang XT

Journal of Hepatocellular Carcinoma 2020, 7:315-330

Published Date: 11 November 2020

Original Research

Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma – A Biomarker That Provides Additional Prognostic Value in AFP Positive Patients

Jensen C, Holm Nielsen S, Eslam M, Genovese F, Nielsen MJ, Vongsuvanh R, Uchila R, van der Poorten D, George J, Karsdal MA, Leeming DJ, Willumsen N

Journal of Hepatocellular Carcinoma 2020, 7:301-313

Published Date: 9 November 2020

Original Research

Association of the Pretreatment Lung Immune Prognostic Index with Survival Outcomes in Advanced Hepatocellular Carcinoma Patients Treated with PD-1 Inhibitors

Chen S, Huang Z, Jia W, Tao H, Zhang S, Ma J, Liu Z, Wang J, Wang L, Cui P, Zhang Z, Huang D, Wu Z, Zheng X, Hu Y

Journal of Hepatocellular Carcinoma 2020, 7:289-299

Published Date: 2 November 2020

Review

Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma

Yu Q, Wu L, Ji J, Feng J, Dai W, Li J, Wu J, Guo C

Journal of Hepatocellular Carcinoma 2020, 7:271-288

Published Date: 29 October 2020

Original Research

miR-3 Encoded by Hepatitis B Virus Downregulates PTEN Protein Expression and Promotes Cell Proliferation

Tang J, Xiao XQ, Jiang Y, Tian Y, Peng Z, Yang M, Xu Z, Gong G

Journal of Hepatocellular Carcinoma 2020, 7:257-269

Published Date: 29 October 2020

Original Research

Prognostic Nomograms for Patients with Hepatocellular Carcinoma After Curative Hepatectomy, with a Focus on Recurrence Timing and Post-Recurrence Management

Xu W, Liu F, Shen X, Li R

Journal of Hepatocellular Carcinoma 2020, 7:233-256

Published Date: 27 October 2020

Original Research

Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients

Liu M, Wu R, Liu X, Xu H, Chi X, Wang X, Zhan M, Wang B, Peng F, Gao X, Shi Y, Wen X, Ji Y, Jin Q, Niu J

Journal of Hepatocellular Carcinoma 2020, 7:219-232

Published Date: 23 October 2020

Original Research

Assessing the Survival Benefit of Surgery and Various Types of Radiation Therapy for Treatment of Hepatocellular Carcinoma: Evidence from the Surveillance, Epidemiology, and End Results Registries

Shi F, Wang C, Kong Y, Yang L, Li J, Zhu G, Guo J, Zheng Q, Zhang B, Wang S

Journal of Hepatocellular Carcinoma 2020, 7:201-218

Published Date: 19 October 2020

Original Research

Elevated Platelet Count is Associated with Poor Survival After Transarterial Chemoembolization Treatment in Patients with Hepatocellular Carcinoma: A Cohort Study

Lu L, Zhang Y, Zheng P, Wu Z, Wang X, Chen Y, Chen X

Journal of Hepatocellular Carcinoma 2020, 7:191-199

Published Date: 15 October 2020

Original Research

Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization

Kobayashi S, Tajiri K, Murayama A, Entani T, Futsukaichi Y, Nagata K, Takahashi K, Yasuda I

Journal of Hepatocellular Carcinoma 2020, 7:181-189

Published Date: 14 October 2020

Original Research

The Clinicopathological and Imaging Characteristics of Primary Hepatic Carcinosarcoma and a Review of the Literature

Bin F, Chen Z, Liu P, Liu J, Mao Z

Journal of Hepatocellular Carcinoma 2020, 7:169-180

Published Date: 13 October 2020

Original Research

Amide Proton Transfer Imaging vs Diffusion Kurtosis Imaging for Predicting Histological Grade of Hepatocellular Carcinoma

Wu B, Jia F, Li X, Zhang M, Han D, Jia Z

Journal of Hepatocellular Carcinoma 2020, 7:159-168

Published Date: 9 October 2020

Expert Opinion

Surgical Management of Localized Hepatocellular Carcinoma in Times of Crisis: A Strategic Approach to Resource Utilization

Tran Cao H, Tzeng CW, Chun YS, Aloia T, Vauthey JN

Journal of Hepatocellular Carcinoma 2020, 7:155-158

Published Date: 28 September 2020

Original Research

Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study

Lacin S, Yalcin S, Karakas Y, Hassan MM, Amin H, Mohamed YI, Rashid A, Morris JS, Xiao L, Qayyum A, Kaseb AO

Journal of Hepatocellular Carcinoma 2020, 7:143-153

Published Date: 16 September 2020

Review

Combination Antiangiogenic and Immunotherapy for Advanced Hepatocellular Carcinoma: Evidence to Date

Raybould AL, Sanoff H

Journal of Hepatocellular Carcinoma 2020, 7:133-142

Published Date: 15 September 2020

Original Research

Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients

Teyateeti A, Mahvash A, Long JP, Abdelsalam ME, Avritscher R, Chasen B, Kaseb AO, Kuban JD, Murthy R, Odisio BC, Teyateeti A, Macapinlac HA, Kappadath SC

Journal of Hepatocellular Carcinoma 2020, 7:117-131

Published Date: 14 September 2020

Review

Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes

Campani C, Bensi C, Milani S, Galli A, Tarocchi M

Journal of Hepatocellular Carcinoma 2020, 7:107-116

Published Date: 30 July 2020

Original Research

Inflammation-Based Prognostic Scores in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma After Liver Transplantation

Ren A, Li Z, Zhang X, Deng R, Ma Y

Journal of Hepatocellular Carcinoma 2020, 7:101-106

Published Date: 7 July 2020

Review

Profile of Cabozantinib for the Treatment of Hepatocellular Carcinoma: Patient Selection and Special Considerations

Debaillon Vesque A, Decraecker M, Blanc JF

Journal of Hepatocellular Carcinoma 2020, 7:91-99

Published Date: 9 June 2020

Review

Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging

Moawad AW, Szklaruk J, Lall C, Blair KJ, Kaseb AO, Kamath A, Rohren SA, Elsayes KM

Journal of Hepatocellular Carcinoma 2020, 7:77-89

Published Date: 23 April 2020

Review

Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment

Dash S, Aydin Y, Widmer KE, Nayak L

Journal of Hepatocellular Carcinoma 2020, 7:45-76

Published Date: 15 April 2020

Case report

Rare Site Hepatocellular Carcinoma Metastasis

Boldo E, Santafe A, Mayol A, Lozoya R, Coret A, Escribano D, Fortea-Sanchis C, Muñoz A, Pastor JC, Perez de Lucia G, Bosch N

Journal of Hepatocellular Carcinoma 2020, 7:39-44

Published Date: 25 March 2020

Review

Impact of Next-Generation Sequencing on Outcomes in Hepatocellular Carcinoma: How Precise Are We Really?

Dominguez DA, Wang XW

Journal of Hepatocellular Carcinoma 2020, 7:33-37

Published Date: 19 March 2020

Original Research

Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2

Liu T, Li S, Wu L, Yu Q, Li J, Feng J, Zhang J, Chen J, Zhou Y, Ji J, Chen K, Mao Y, Wang F, Dai W, Fan X, Wu J, Guo C

Journal of Hepatocellular Carcinoma 2020, 7:19-31

Published Date: 18 February 2020

Review

The Immune Modulation Effect of Locoregional Therapies and Its Potential Synergy with Immunotherapy in Hepatocellular Carcinoma

Singh P, Toom S, Avula A, Kumar V, Rahma OE

Journal of Hepatocellular Carcinoma 2020, 7:11-17

Published Date: 10 February 2020

Original Research

Exploring Metabolic Consequences of CPS1 and CAD Dysregulation in Hepatocellular Carcinoma by Network Reconstruction

Dumenci OE, U AMR, Khan SA, Holmes E, Taylor-Robinson SD

Journal of Hepatocellular Carcinoma 2020, 7:1-9

Published Date: 7 January 2020

Review

Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves

El Kassas M, Tawheed A, Eltabbakh M, Kaseb A

Journal of Hepatocellular Carcinoma 2019, 6:183-191

Published Date: 19 November 2019

Original Research

Socioeconomic And Survival Differences Among Minorities With Hepatocellular Carcinoma In Florida

Jones PD, Scheinberg AR, Muenyi V, Gonzalez-Diaz J, Martin PM, Kobetz E

Journal of Hepatocellular Carcinoma 2019, 6:167-181

Published Date: 15 November 2019

Review

Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine

Duan J, Wu Y, Liu J, Zhang J, Fu Z, Feng T, Liu M, Han J, Li Z, Chen S

Journal of Hepatocellular Carcinoma 2019, 6:151-166

Published Date: 18 October 2019

Original Research

Hepatitis B And Hepatitis C Viral Infections And Associated Factors Among Patients With Diabetes Visiting Gondar Referral Teaching Hospital, Northwest Ethiopia: A Comparative Cross-Sectional Study

Million Y, Teklu T, Alemu S, Ferede A, Belachew T, Desta K

Journal of Hepatocellular Carcinoma 2019, 6:143-150

Published Date: 8 October 2019

Review

Status of, and strategies for improving, adherence to HCC screening and surveillance

Francica G, Borzio M

Journal of Hepatocellular Carcinoma 2019, 6:131-141

Published Date: 24 July 2019

Original Research

Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma

Zakka K, Jiang R, Alese OB, Shaib WL, Wu C, Wedd JP, Sellers MT, Behera M, El-Rayes BF, Akce M

Journal of Hepatocellular Carcinoma 2019, 6:119-129

Published Date: 22 July 2019

Review

Intermediate stage hepatocellular carcinoma: a summary review

Elshaarawy O, Gomaa A, Omar H, Rewisha E, Waked I

Journal of Hepatocellular Carcinoma 2019, 6:105-117

Published Date: 11 July 2019

Original Research

Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve

Fidelman N, Johanson C, Kohi MP, Kolli KP, Kohlbrenner RM, Lehrman ED, Taylor AG, Kelley RK, Yao FY, Roberts JP, Kerlan RK

Journal of Hepatocellular Carcinoma 2019, 6:93-103

Published Date: 17 June 2019

Review

Post-translational modifiers of liver kinase B1/serine/threonine kinase 11 in hepatocellular carcinoma

Delgado TC, Lopitz-Otsoa F, Martínez-Chantar ML

Journal of Hepatocellular Carcinoma 2019, 6:85-91

Published Date: 6 June 2019

Review

Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives

Lu LC, Chang CJ, Hsu CH

Journal of Hepatocellular Carcinoma 2019, 6:71-84

Published Date: 7 May 2019

Review

LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance

Elsayes KM, Kielar AZ, Chernyak V, Morshid A, Furlan A, Masch WR, Marks RM, Kamaya A, Do RKG, Kono Y, Fowler KJ, Tang A, Bashir MR, Hecht EM, Jambhekar K, Lyshchik A, Rodgers SK, Heiken JP, Kohli M, Fetzer DT, Wilson SR, Kassam Z, Mendiratta-Lala M, Singal AG, Lim CS, Cruite I, Lee J, Ash R, Mitchell DG, McInnes MDF, Sirlin CB

Journal of Hepatocellular Carcinoma 2019, 6:49-69

Published Date: 5 February 2019

Meeting Report

Road map for fibrolamellar carcinoma: progress and goals of a diversified approach

Kastenhuber ER, Craig J, Ramsey J, Sullivan KM, Sage J, de Oliveira S, Riehle KJ, Scott JD, Gordan JD, Bardeesy N, Abou-Alfa GK

Journal of Hepatocellular Carcinoma 2019, 6:41-48

Published Date: 31 January 2019

Review

Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date

Personeni N, Pressiani T, Rimassa L

Journal of Hepatocellular Carcinoma 2019, 6:31-39

Published Date: 31 January 2019

Review

Weighing the benefits of hepatocellular carcinoma surveillance against potential harms

Geh D, Rana FA, Reeves HL

Journal of Hepatocellular Carcinoma 2019, 6:23-30

Published Date: 14 January 2019

Review

Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions

Stavraka C, Rush H, Ross P

Journal of Hepatocellular Carcinoma 2019, 6:11-21

Published Date: 28 December 2018

Review

Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria

Amado V, Rodríguez-Perálvarez M, Ferrín G, De la Mata M

Journal of Hepatocellular Carcinoma 2019, 6:1-10

Published Date: 21 December 2018

Original Research

Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)

Azim HA, Omar A, Atef H, Zawahry H, Shaker MK, Abdelmaksoud AHK, EzzElarab M, Abdel-Rahman O, Ismail M, Kassem L, Waked I

Journal of Hepatocellular Carcinoma 2018, 5:109-119

Published Date: 19 November 2018

Review

Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist

Quaglia A

Journal of Hepatocellular Carcinoma 2018, 5:99-108

Published Date: 8 November 2018

Review

Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein

Gilabert M, Raoul JL

Journal of Hepatocellular Carcinoma 2018, 5:91-98

Published Date: 2 November 2018

Review

Update on hepatocellular carcinoma from the 2018 Gastrointestinal Cancer Symposium (ASCO GI)

de Jesus VHF, Dettino ALA

Journal of Hepatocellular Carcinoma 2018, 5:87-90

Published Date: 3 October 2018

Original Research

Hepatitis C virus-associated hepatocellular carcinoma as a second primary malignancy: exposing an overlooked presentation of liver cancer

Dandachi D, Hassan M, Kaseb A, Angelidakis G, Torres HA

Journal of Hepatocellular Carcinoma 2018, 5:81-86

Published Date: 2 August 2018

Review

Hepatocellular cancer pain: impact and management challenges

Christian-Miller N, Frenette C

Journal of Hepatocellular Carcinoma 2018, 5:75-80

Published Date: 19 July 2018

Review

Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance

Khalaf AM, Fuentes D, Morshid AI, Burke MR, Kaseb AO, Hassan M, Hazle JD, Elsayes KM

Journal of Hepatocellular Carcinoma 2018, 5:61-73

Published Date: 27 June 2018

Case Series

Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance

Griffith AS, Hayashi PH, Burke LMB, McRee AJ

Journal of Hepatocellular Carcinoma 2018, 5:55-59

Published Date: 31 May 2018

Editorial

Editorial: charting the future of hepatocellular carcinoma publications

Kaseb AO

Journal of Hepatocellular Carcinoma 2018, 5:51-54

Published Date: 8 May 2018

Review

Basic MRI for the liver oncologists and surgeons

Vu LN, Morelli JN, Szklaruk J

Journal of Hepatocellular Carcinoma 2018, 5:37-50

Published Date: 10 April 2018

Clinical Trial Report

Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt

Shaker MK, Montasser IF, Sakr M, Elgharib M, Dabbous HM, Ebada H, El Dorry A, Bahaa M, El Meteini M

Journal of Hepatocellular Carcinoma 2018, 5:29-36

Published Date: 27 February 2018

Review

Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma

Najjar M, Agrawal S, Emond JC, Halazun KJ

Journal of Hepatocellular Carcinoma 2018, 5:17-28

Published Date: 18 January 2018

Original Research

Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma

Feun LG, Wangpaichitr M, Li YY, Kwon D, Richman SP, Hosein PJ, Savaraj N

Journal of Hepatocellular Carcinoma 2018, 5:9-15

Published Date: 12 January 2018

Original Research

Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma

Liang B, Yao SY, Zhou JP, Li ZK, Liu TQ

Journal of Hepatocellular Carcinoma 2018, 5:1-7

Published Date: 12 January 2018

Original Research

Characterization of alpha-fetoprotein effects on dendritic cell and its function as effector immune response activator

Suryatenggara J, Wibowo H, Atmodjo WL, Mathew G

Journal of Hepatocellular Carcinoma 2017, 4:139-151

Published Date: 28 November 2017

Review

Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions

Ray EM, Sanoff HK

Journal of Hepatocellular Carcinoma 2017, 4:131-138

Published Date: 8 November 2017

Original Research

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma

Fateen W, Khan F, O’Neill RJ, James MW, Ryder SD, Aithal GP

Journal of Hepatocellular Carcinoma 2017, 4:123-130

Published Date: 16 October 2017

Clinical Trial Report

A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect

de la Torre AN, Contractor S, Castaneda I, Cathcart CS, Razdan D, Klyde D, Kisza P, Gonzales SF, Salazar AM

Journal of Hepatocellular Carcinoma 2017, 4:111-121

Published Date: 7 August 2017

Review

Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review

Sacco R, Tapete G, Simonetti N, Sellitri R, Natali V, Melissari S, Cabibbo G, Biscaglia L, Bresci G, Giacomelli L

Journal of Hepatocellular Carcinoma 2017, 4:105-110

Published Date: 27 July 2017

Review

Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies

Galun D, Srdic-Rajic T, Bogdanovic A, Loncar Z, Zuvela M

Journal of Hepatocellular Carcinoma 2017, 4:93-103

Published Date: 11 July 2017

Review

Hepatocellular carcinoma: early-stage management challenges

Erstad DJ, Tanabe KK

Journal of Hepatocellular Carcinoma 2017, 4:81-92

Published Date: 23 June 2017

Review

Screening for hepatocellular carcinoma: patient selection and perspectives

Fateen W, Ryder SD

Journal of Hepatocellular Carcinoma 2017, 4:71-79

Published Date: 17 May 2017

Clinical Trial Report

Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

Tarakanovskaya MG, Chinburen J, Batchuluun P, Munkhzaya C, Purevsuren G, Dandii D, Hulan T, Oyungerel D, Kutsyna GA, Reid AA, Borisova V, Bain AI, Jirathitikal V, Bourinbaiar AS

Journal of Hepatocellular Carcinoma 2017, 4:59-69

Published Date: 12 April 2017

Review

Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives

Zimmerman A, Grand D, Charpentier KP

Journal of Hepatocellular Carcinoma 2017, 4:49-58

Published Date: 13 March 2017

Case Series

A single institution report of 19 hepatocellular carcinoma patients with bile duct tumor thrombus

Chotirosniramit A, Liwattanakun A, Lapisatepun W, Ko-iam W, Sandhu T, Junrungsee S

Journal of Hepatocellular Carcinoma 2017, 4:41-47

Published Date: 7 March 2017

Expert Opinion

Liver Imaging Reporting and Data System: an expert consensus statement

Elsayes KM, Kielar AZ, Agrons MM, Szklaruk J, Tang A, Bashir MR, Mitchell DG, Do RK, Fowler KJ, Chernyak V, Sirlin CB

Journal of Hepatocellular Carcinoma 2017, 4:29-39

Published Date: 17 February 2017

Review

Needle track seeding after radiofrequency ablation for hepatocellular carcinoma: prevalence, impact, and management challenge

Francica G

Journal of Hepatocellular Carcinoma 2017, 4:23-27

Published Date: 20 January 2017

Review

Pediatric hepatocellular carcinoma: challenges and solutions

Schmid I, von Schweinitz D

Journal of Hepatocellular Carcinoma 2017, 4:15-21

Published Date: 16 January 2017

Commentary

Strengthening the case that elevated levels of programmed death ligand 1 predict poor prognosis in hepatocellular carcinoma patients

Zhong J, Luo C, Zhang C, Li L

Journal of Hepatocellular Carcinoma 2017, 4:11-13

Published Date: 30 December 2016

Review

Surgical resection of localized hepatocellular carcinoma: patient selection and special consideration

Ma KW, Cheung TT

Journal of Hepatocellular Carcinoma 2017, 4:1-9

Published Date: 28 December 2016

Review

Profile of tivantinib and its potential in the treatment of hepatocellular carcinoma: the evidence to date

Pievsky D, Pyrsopoulos N

Journal of Hepatocellular Carcinoma 2016, 3:69-76

Published Date: 15 November 2016

Review

GPC-3 in hepatocellular carcinoma: current perspectives

Wu Y, Liu H, Ding H

Journal of Hepatocellular Carcinoma 2016, 3:63-67

Published Date: 8 November 2016

Review

Minimally invasive image-guided therapies for hepatocellular carcinoma

Abdelsalam ME, Murthy R, Avritscher R, Mahvash A, Wallace MJ, Kaseb AO, Odisio BC

Journal of Hepatocellular Carcinoma 2016, 3:55-61

Published Date: 11 October 2016

Review

Hepatocellular carcinoma: a review

Balogh J, Victor III D, Asham EH, Burroughs SG, Boktour M, Saharia A, Li X, Ghobrial RM, Monsour Jr HP

Journal of Hepatocellular Carcinoma 2016, 3:41-53

Published Date: 5 October 2016

Commentary

Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentary

Mizejewski GJ

Journal of Hepatocellular Carcinoma 2016, 3:37-40

Published Date: 21 September 2016

Review

Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma

Trojan J, Waidmann O

Journal of Hepatocellular Carcinoma 2016, 3:31-36

Published Date: 21 September 2016

Review

Transarterial radioembolization for hepatocellular carcinoma: a review

Sacco R, Conte C, Tumino E, Parisi G, Marceglia S, Metrangolo S, Eggenhoffner R, Bresci G, Cabibbo G, Giacomelli L

Journal of Hepatocellular Carcinoma 2016, 3:25-29

Published Date: 25 July 2016

Original Research

Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patients

Atta MM, Atta HM, Gad MA, Rashed LA, Said EM, Hassanien SE, Kaseb AO

Journal of Hepatocellular Carcinoma 2016, 3:19-24

Published Date: 14 June 2016

Review

Hepatocellular carcinoma in elderly patients: challenges and solutions

Brunot A, Le Sourd S, Pracht M, Edeline J

Journal of Hepatocellular Carcinoma 2016, 3:9-18

Published Date: 17 June 2016

Original Research

Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma

Mahvash A, Murthy R, Odisio BC, Raghav KP, Girard L, Cheung S, Nguyen V, Ensor J, Gadani S, Elsayes KM, Abdel-Wahab R, Hassan M, Shalaby AS, Yao JC, Wallace MJ, Kaseb AO

Journal of Hepatocellular Carcinoma 2016, 3:1-7

Published Date: 5 February 2016

Review

Fibrolamellar hepatocellular carcinoma: current clinical perspectives

Lafaro KJ, Pawlik TM

Journal of Hepatocellular Carcinoma 2015, 2:151-157

Published Date: 9 October 2015

Review

Role of endoscopic ultrasound in diagnosis and management of hepatocellular carcinoma

Koduru P, Suzuki R, Lakhtakia S, Ramchandani M, Makmun D, Bhutani MS

Journal of Hepatocellular Carcinoma 2015, 2:143-149

Published Date: 6 October 2015

Review

Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma

Abdel-Wahab R, Shehata S, Hassan MM, Habra MA, Eskandari G, Tinkey PT, Mitchell J, Lee JS, Amin HM, Kaseb AO

Journal of Hepatocellular Carcinoma 2015, 2:131-142

Published Date: 18 September 2015

Review

Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy

Jang JH, Lee JW, Hong JT, Jin YJ

Journal of Hepatocellular Carcinoma 2015, 2:123-129

Published Date: 2 September 2015

Editorial

Whither α-FP in the diagnosis of hepatocellular carcinoma?

Kew MC

Journal of Hepatocellular Carcinoma 2015, 2:119-121

Published Date: 24 August 2015

Review

State-of-the-art cross-sectional liver imaging: beyond lesion detection and characterization

Luersen GF, Bhosale P, Szklaruk J

Journal of Hepatocellular Carcinoma 2015, 2:101-117

Published Date: 10 July 2015

Review

The androgen receptor as an emerging target in hepatocellular carcinoma

Kanda T, Yokosuka O

Journal of Hepatocellular Carcinoma 2015, 2:91-99

Published Date: 26 June 2015

Original Research

Ambovex® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial

Salama H, Ahmad H, Elchagea I, Zekri AR, Medhat E, Bahnassy A, Lange M, Rabbat M, de la Torre AN, Punamiya P

Journal of Hepatocellular Carcinoma 2015, 2:79-89

Published Date: 22 June 2015

Review

Emerging role of Hpo signaling and YAP in hepatocellular carcinoma

Valero V III, Pawlik TM, Anders RA

Journal of Hepatocellular Carcinoma 2015, 2:69-78

Published Date: 18 June 2015

Original Research

Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy

Gao F, Jing P, Liu J, Lu YF, Zhang PC, Han W, Liu GL, Ru N, Cui GH, Sun CL, Che YB, Zhang HM, Hu QL, Wang HY, Wu YL, Guan CJ, Fu Q, Ma ZL, Yu BF

Journal of Hepatocellular Carcinoma 2015, 2:57-68

Published Date: 9 June 2015

Editorial

Hepatocellular carcinoma ablation and possible immunity in the age of nanosecond pulsed electric fields

Beebe SJ

Journal of Hepatocellular Carcinoma 2015, 2:49-55

Published Date: 22 May 2015

Original Research

Early α-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib

Lee SH, Kim BK, Kim SU, Park JY, Kim DY, Ahn SH, Han KH

Journal of Hepatocellular Carcinoma 2015, 2:39-47

Published Date: 28 April 2015

Review

c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma

Granito A, Guidetti E, Gramantieri L

Journal of Hepatocellular Carcinoma 2015, 2:29-38

Published Date: 24 April 2015

Review

A clinical perspective of the link between metabolic syndrome and hepatocellular carcinoma

Cauchy F, Belghiti J

Journal of Hepatocellular Carcinoma 2015, 2:19-27

Published Date: 23 February 2015

Review

Emerging role of Toll-like receptor 4 in hepatocellular carcinoma

Yang J, Li M, Zheng QC

Journal of Hepatocellular Carcinoma 2015, 2:11-17

Published Date: 16 February 2015

Original Research

Untreated hepatocellular carcinoma in Egypt: outcome and prognostic factors

Zeeneldin AA, Salem SE, Darwish AD, El-Gammal MM, Hussein MM, Saadeldin M

Journal of Hepatocellular Carcinoma 2015, 2:3-9

Published Date: 30 January 2015

Editorial

Welcome to Journal of Hepatocellular Carcinoma

Kaseb AO

Journal of Hepatocellular Carcinoma 2015, 2:1-2

Published Date: 9 January 2015

Original Research

Chemoembolization with drug-eluting microspheres (DEM-TACE) for hepatocellular carcinoma: single-center review of safety and efficacy

Bishay VL, Maglione K, Khanna R, Lee KM, Fischman AM, Lookstein RA, Kim E

Journal of Hepatocellular Carcinoma 2014, 1:187-193

Published Date: 27 November 2014

Review

Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma

Aiolfi R, Sitia G

Journal of Hepatocellular Carcinoma 2014, 1:183-186

Published Date: 13 November 2014

Review

Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments

Cappelli A, Pettinato C, Golfieri R

Journal of Hepatocellular Carcinoma 2014, 1:163-182

Published Date: 3 November 2014

Original Research

Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models

Braidwood L, Learmonth K, Graham A, Conner J

Journal of Hepatocellular Carcinoma 2014, 1:149-161

Published Date: 16 October 2014

Review

Radiological diagnosis of hepatocellular carcinoma

Bargellini I, Battaglia V, Bozzi E, Lauretti DL, Lorenzoni G, Bartolozzi C

Journal of Hepatocellular Carcinoma 2014, 1:137-148

Published Date: 9 September 2014

Review

Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma

Hsu HT, Chi CW

Journal of Hepatocellular Carcinoma 2014, 1:127-135

Published Date: 26 August 2014

Review

Hepatocellular carcinoma: epidemiology and risk factors

Kew MC

Journal of Hepatocellular Carcinoma 2014, 1:115-125

Published Date: 13 August 2014

Case Series

Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series

Torres HA, Kaseb A, Mahale P, Miller E, Frenette C

Journal of Hepatocellular Carcinoma 2014, 1:109-114

Published Date: 16 July 2014

Review

Clinical utility of imaging for evaluation of hepatocellular carcinoma

Murakami T, Tsurusaki M, Hyodo T, Imai Y

Journal of Hepatocellular Carcinoma 2014, 1:101-108

Published Date: 14 July 2014

Review

Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives

Hsu CH, Shen YC, Shao YY, Hsu C, Cheng AL

Journal of Hepatocellular Carcinoma 2014, 1:85-99

Published Date: 12 June 2014

Review

New insights on the role of epigenetic alterations in hepatocellular carcinoma

Frau M, Feo CF, Feo F, Pascale RM

Journal of Hepatocellular Carcinoma 2014, 1:65-83

Published Date: 12 June 2014

Original Research

Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinoma

Gabeen AA, Abdel-Hamid FF, El-Houseini ME, Fathy SA

Journal of Hepatocellular Carcinoma 2014, 1:55-63

Published Date: 9 June 2014

Review

Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma

Coleman SJ, Grose RP, Kocher HM

Journal of Hepatocellular Carcinoma 2014, 1:43-54

Published Date: 29 May 2014

Review

Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma

Ofuji K, Saito K, Yoshikawa T, Nakatsura T

Journal of Hepatocellular Carcinoma 2014, 1:35-42

Published Date: 21 May 2014

Review

Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinoma

Li L, Diao W, Zen K

Journal of Hepatocellular Carcinoma 2014, 1:21-33

Published Date: 21 May 2014

Review

Emerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma

Akiel M, Rajasekaran D, Gredler R, Siddiq A, Srivastava J, Robertson C, Jariwala NH, Fisher PB, Sarkar D

Journal of Hepatocellular Carcinoma 2014, 1:9-19

Published Date: 26 March 2014

Review

A review on the diagnosis and treatment of hepatocellular carcinoma with a focus on the role of Wnts and the dickkopf family of Wnt inhibitors

Shi J, Keller JM, Zhang J, Keller ET

Journal of Hepatocellular Carcinoma 2014, 1:1-7

Published Date: 6 March 2014